Growing our impact for patients
We will maximise the impact of our research for patients by engaging with industry, funders, donors and the public, building partnerships in the UK and internationally, and influencing the uptake of our advances into routine healthcare.
It is our aim as an organisation to change the lives of people with cancer. We carry out extraordinary, world-leading research, but that alone is not enough to maximise our impact. We also work across academia, Government and industry to ensure our findings benefit society and the economy, and to grow our funding for research so we can achieve even more in the future.
We are proud that by working with our partners, our research is helping change the lives of people with cancer.
We have ambitions to grow our impact even further. We will articulate the benefits of our research for society through an expanded programme of knowledge exchange, sector leadership and influencing. We will continue to work with industry and other partners to enhance the ICR’s global impact, and we will increase income for our future research by working with partners, donors and funders.
The ICR and The Royal Marsden are determined that our research should have the greatest possible impact for people with cancer and their families. We believe our world-class research and ability to bridge rapidly between the laboratory and the clinic can have a huge impact for people with cancer not only in the UK, but globally. In doing so, our work can play a vital role in helping grow the UK’s economy.
It is crucial that we lead through networks, articulate the benefits of our research for society and influence the uptake of our findings into routine healthcare.
We will engage with patients and their families to make sure their voice is heard, champion diversity in cancer research and push for equity in access to innovations.
Working through our clinical networks we will shape national strategy, spearheading the adoption of new treatments and approaches to early detection.
We will engage with funders, the public and the Government about our research, and use patient data to show the benefits of our work for society.
The ICR works with partners in industry, the NHS and academia to maximise the impact of our research for patients. We are aiming to build the impact of our work with existing partners, and to establish new relationships where we believe they can expand the scope of our research and increase the chances that our findings will reach patients.
We will continue to commercialise our research by building a culture of entrepreneurship to help our researchers translate their work into benefits for patients. By strengthening our existing partnerships and creating new ones, we will accelerate the passage of our research findings into the clinic, and maximise the chances that patients will benefit.
We will also further develop The London Cancer Hub as a vibrant life-science ecosystem, working with the London Borough of Sutton, occupiers at the Innovation Gateway and commercial developers.
The ICR’s research is changing lives, and gaining more funding for our work will increase our future impact.
Our researchers and professional services staff will be working closely together to grow our income and build funding for our future research. We plan to develop new programmes of income generation focused on the ICR’s research centres.
We believe we can grow our impact by deepening our bonds with donors and funders, strengthening our brand, and expanding our reach internationally.
We intend to expand our philanthropic activities and to embed a culture of fundraising across our organisation.
Related news
Related blogs
